Target intelligence / Profile preview

Vaginal microbiota community (VMC) (VMC)

Target
VMC
Molecular classification
Microbiome, Microbial community
01

Overview

The vaginal microbiota community is a complex ecosystem of microorganisms inhabiting the vaginal mucosa, primarily dominated by Lactobacillus species in healthy individuals of reproductive age (NIH, 2023). This community serves as a critical biological barrier, where Lactobacilli produce lactic acid to maintain an acidic environment (pH < 4.5), inhibiting the growth of pathogenic bacteria and viruses (PubMed, 2021). Dysbiosis, characterized by a transition from Lactobacillus dominance to a diverse mixture of anaerobic bacteria, leads to conditions such as bacterial vaginosis (BV) and increases susceptibility to sexually transmitted infections and adverse pregnancy outcomes like preterm birth (Nature Microbiology, 2020). Therapeutic targeting of this community involves the use of narrow or broad-spectrum antibiotics to eliminate pathogens, as well as the administration of live biotherapeutic products (probiotics) or vaginal microbiota transplants to restore a healthy microbial balance (The Lancet, 2019). Understanding the community state types (CSTs) is essential for developing personalized interventions to maintain reproductive health and prevent pelvic inflammatory diseases (Frontiers in Cellular and Infection Microbiology, 2022). Current research focuses on the role of specific strains, such as Lactobacillus crispatus, in providing long-term protection against recurrence of infection (PubMed, 2020).

Other names
Vaginal microbiomeVaginal floraVaginal microfloraVaginal microbial ecosystem
02

Mechanism of action

Restoration of microbial homeostasis through competitive exclusion, production of antimicrobial metabolites (lactic acid, hydrogen peroxide), and reduction of pro-inflammatory anaerobic bacteria.

03

Biological functions

Pathogen defensepH regulationImmune modulationMetabolic homeostasisBarrier function
04

Disease associations

Bacterial vaginosisVulvovaginal candidiasisSexually transmitted infectionsPreterm birthPelvic inflammatory diseaseAerobic vaginitis
05

Safety considerations

Antibiotic resistanceRecurrence of dysbiosisRisk of pathogen transfer in microbiota transplantsDisruption of commensal flora
06

Interacting drugs

Metronidazole

6 more in the full profile.

07

Biomarkers

Nugent scoreVaginal pHLactobacillus abundanceGardnerella vaginalis concentrationCommunity State Types (CSTs)Ametyst score

Beyond the preview

Go deeper on Vaginal microbiota community (VMC) (VMC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal microbiota community (VMC) (VMC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call